CAS 56455-90-4 MFCD00236955-4,4’-((4,4’-Diamino-[1,1’-Biphenyl]-3,3’-Diyl)Bis(Oxy))Dibutyric Acid Dihydrochloride 4,4’-((4,4’-二氨基-[1,1’-联苯]-3,3’-二基)双(氧基))二丁酸二盐酸盐 TAO{mole}

4,4’-((4,4’-Diamino-[1,1’-Biphenyl]-3,3’-Diyl)Bis(Oxy))Dibutyric Acid Dihydrochloride 4,4’-((4,4’-二氨基-[1,1’-联苯]-3,3’-二基)双(氧基))二丁酸二盐酸盐

CAS 56455-90-4 MFCD00236955

化学结构图

SMILES: Cl.Cl.NC1C=CC(=CC=1OCCCC(O)=O)C1C=C(OCCCC(O)=O)C(N)=CC=1

化学属性

Mol. Formula	C20H24N2O6· 2HCl
Mol. Weight	461.34

别名和识别编码

Chemical Name	4,4’-((4,4’-Diamino-[1,1’-Biphenyl]-3,3’-Diyl)Bis(Oxy))Dibutyric Acid Dihydrochloride
Synonym	γ,γ'-(4,4'-Diamino-3,3'-biphenylylenedioxy)dibutyric acid Butyric acid, 4,4'-(4,4'-diamino-m,m'-biphenylenedioxy)di-, gamma,gamma'-3,3'-Benzidine dioxydibutyric acid dihydrochloride Dicarboxidine dihydrochloride
MDL Number	MFCD00236955
PubChem Substance ID	24893982
Wiswesser Line Notation	QV3OR BZ ER DZ CO3VQ &GH 2
CAS Number	56455-90-4
Chemical Name Translation	4,4’-((4,4’-二氨基-[1,1’-联苯]-3,3’-二基)双(氧基))二丁酸二盐酸盐

信息真实价格透明资金保障专业采购外包团队在线服务

品牌质保精细包装现货库存一流品牌服务

安全信息

GHS Symbol

WGK Germany3

Precautionary statements

P261 Avoid breathing dust/fume/gas/mist/vapours/spray. 避免吸入粉尘/烟/气体/烟雾/蒸汽/喷雾。
P305+P351+P338

Hazard statements

H315 Causes skin irritation 会刺激皮肤
H319 Causes serious eye irritation 严重刺激眼睛
H335 May cause respiratory irritation 可能导致呼吸道刺激

RTECSEK7770000

Signal word Warning

Personal Protective Equipment dust mask type N95 (US), Eyeshields, Gloves

Safety Statements

S26 In case of contact with eyes, rinse immediately with plenty of water and seek medical advice 眼睛接触后，立即用大量水冲洗并征求医生意见；
S36 Wear suitable protective clothing 穿戴适当的防护服；
S22 Do not breathe dust 不要吸入粉尘；

Hazard Codes Xi

Risk Statements

R36/37/38 Irritating to eyes, respiratory system and skin 对眼睛、呼吸系统和皮肤有刺激性

TYPE OF TEST            : TDLo - Lowest published toxic dose
ROUTE OF EXPOSURE       : Subcutaneous
SPECIES OBSERVED        : Rodent - rat
DOSE/DURATION           : 21250 mg/kg/2Y-I
TOXIC EFFECTS :
   Tumorigenic - equivocal tumorigenic agent by RTECS criteria
   Tumorigenic - tumors at site of application
REFERENCE :
   JJIND8 JNCI, Journal of the National Cancer Institute.  (Washington, DC)
   V.61-79, 1978-87. For publisher information, see JNCIEQ.
   Volume(issue)/page/year: 62,301,1979

TYPE OF TEST            : TD - Toxic dose (other than lowest)
ROUTE OF EXPOSURE       : Subcutaneous
SPECIES OBSERVED        : Rodent - rat
DOSE/DURATION           : 23400 mg/kg/2Y-I
TOXIC EFFECTS :
   Tumorigenic - equivocal tumorigenic agent by RTECS criteria
   Kidney, Ureter, Bladder - tumors
   Tumorigenic - tumors at site of application
REFERENCE :
   ARZNAD Arzneimittel-Forschung. Drug Research.  (Editio Cantor Verlag,
   Postfach 1255, W-7960 Aulendorf, Fed. Rep. Ger.)  V.1-    1951-
   Volume(issue)/page/year: 29,187,1979

TYPE OF TEST            : TD - Toxic dose (other than lowest)
ROUTE OF EXPOSURE       : Subcutaneous
SPECIES OBSERVED        : Rodent - rat
DOSE/DURATION           : 37500 mg/kg/2Y-I
TOXIC EFFECTS :
   Tumorigenic - equivocal tumorigenic agent by RTECS criteria
   Tumorigenic - tumors at site of application
REFERENCE :
   VOONAW Voprosy Onkologii.  Problems of Oncology.  For English translation,
   see PONCAU. (V/O Mezhdunarodnaya Kniga, 113095 Moscow, USSR)  V.1-10,
   1928-37; V.1-    1955-  Volume(issue)/page/year: 25(7),43,1979

TYPE OF TEST            : LDLo - Lowest published lethal dose
ROUTE OF EXPOSURE       : Intravenous
SPECIES OBSERVED        : Rodent - mouse
DOSE/DURATION           : >600 mg/kg
TOXIC EFFECTS :
   Details of toxic effects not reported other than lethal dose value
REFERENCE :
   ARZNAD Arzneimittel-Forschung. Drug Research.  (Editio Cantor Verlag,
   Postfach 1255, W-7960 Aulendorf, Fed. Rep. Ger.)  V.1-    1951-
   Volume(issue)/page/year: 29,187,1979

TYPE OF TEST            : LDLo - Lowest published lethal dose
ROUTE OF EXPOSURE       : Oral
SPECIES OBSERVED        : Rodent - mouse
DOSE/DURATION           : >1200 mg/kg
TOXIC EFFECTS :
   Details of toxic effects not reported other than lethal dose value
REFERENCE :
   ARZNAD Arzneimittel-Forschung. Drug Research.  (Editio Cantor Verlag,
   Postfach 1255, W-7960 Aulendorf, Fed. Rep. Ger.)  V.1-    1951-
   Volume(issue)/page/year: 29,187,1979